Patents by Inventor Robert Steffan

Robert Steffan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 4-(Indazol-3-yl)phenols
    Publication number: 20070225349
    Abstract: This invention provides compound of formulae I or II having the structure wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined in the specification or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.
    Type: Application
    Filed: May 16, 2007
    Publication date: September 27, 2007
    Applicant: Wyeth
    Inventors: Robert Steffan, Edward Matelan, Mark Ashwell, William Solvibile
  • [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones
    Publication number: 20060106084
    Abstract: This invention provides anti-inflammatory agents of formula I, having the structure wherein A and R1-R10 are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.
    Type: Application
    Filed: October 27, 2005
    Publication date: May 18, 2006
    Applicant: Wyeth
    Inventors: Robert Steffan, Edward Matelan
  • Phenanthridine carbonyl phenols
    Publication number: 20060058337
    Abstract: The present invention relates generally to phenanthridine carbonyl compositions such as substituted phenanthridine carbonyl phenols and methods of using them.
    Type: Application
    Filed: August 30, 2005
    Publication date: March 16, 2006
    Applicant: WYETH
    Inventors: Robert Steffan, William Moore, Eugene Trybulski, Albert Molinari
  • Indazoles useful in treating cardiovascular diseases
    Publication number: 20060030612
    Abstract: This invention provides compounds of Formula (I) or (Ia): that are useful in the treatment or inhibition of LXR mediated diseases.
    Type: Application
    Filed: August 1, 2005
    Publication date: February 9, 2006
    Applicant: Wyeth
    Inventors: Robert Steffan, Edward Matelan, Stephen Bowen, John Ullrich, Jay Wrobel, Edouard Zamaratski, Lars Kruger, Annabel Hedemyr, Aiping Cheng, Tomas Hansson, Rayomand Unwalla, Christopher Miller, Patrik Rhonnstad